First National Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.81M Sell
9,582
-780
-8% -$791K 1.29% 14
2025
Q4
$11.1M Buy
10,362
+153
+1% +$146K 1.53% 12
2025
Q3
$7.79M Buy
10,209
+80
+0.8% +$59.5K 1.06% 14
2025
Q2
$7.9M Buy
10,129
+158
+2% +$123K 1.16% 12
2025
Q1
$8.23M Sell
9,971
-1,881
-16% -$1.57M 1.32% 12
2024
Q4
$9.15M Buy
11,852
+334
+3% +$277K 1.48% 11
2024
Q3
$10.2M Buy
11,518
+527
+5% +$474K 1.63% 11
2024
Q2
$9.95M Sell
10,991
-1,008
-8% -$806K 1.82% 8
2024
Q1
$7.13M Buy
11,999
+3,447
+40% +$2.45M 1.59% 9
2023
Q4
$4.99M Buy
8,552
+2,695
+46% +$1.57M 1.43% 10
2023
Q3
$3.15M Buy
5,857
+1,509
+35% +$778K 1.4% 11
2023
Q2
$2.04M Sell
4,348
-734
-14% -$308K 1.88% 6
2023
Q1
$1.75M Buy
5,082
+393
+8% +$133K 1.98% 7
2022
Q4
$1.72M Buy
4,689
+507
+12% +$180K 2.2% 4
2022
Q3
$1.35M Buy
4,182
+1,182
+39% +$374K 2% 5
2022
Q2
$973K Buy
+3,000
New +$901K 2.02% 7

Other funds holding LLY

First National Advisers's LLY Position: Q1 2026 in Review

First National Advisers reduced its Eli Lilly (LLY) stake by 7.5% in Q1 2026, selling an estimated $791K and leaving 9,582 shares worth $8.81M. The position accounts for 1.29% of the portfolio, ranked #14.

First National Advisers first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $11.1M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • First National Advisers held 9,582 shares of Eli Lilly worth $8.81M as of Q1 2026.
  • First National Advisers sold 780 Eli Lilly shares in Q1 2026, an estimated $791K.
  • Eli Lilly made up 1.29% of First National Advisers's portfolio in Q1 2026, its #14 holding.
  • First National Advisers first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
  • First National Advisers's Eli Lilly position peaked at $11.1M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on First National Advisers's 13F filing for Q1 2026, filed 8 May 2026.